🔥🐔 BizChicken 🐔🔥
Companies Similar to Minerva Neurosciences, Inc.
Sign Up Today!
Sign up for BizChicken and discover more about the corporations around you.
Biogen Inc.
TECFIDERA, VUMERITY, AVONEX, PLEGRIDY, TYSABRI, FAMPYRA, SPINRAZA, FUMADERM, BENEPALI, ADUHELM, IMRALDI, FLIXABI, RITUXAN, RITUXAN HYCELA, GAZYVA, OCREVUS
Biogen Inc. focuses on discovering, developing, manufacturing, and delivering therapies for neurological and neurodegenerative diseases, including multiple sclerosis, spinal muscular atrophy, plaque psoriasis, Alzheimer's disease, and various cancers and autoimmune conditions.
About | About | Vision/Values | Leadership | Foundation | Contact | Careers | Careers | Careers | Careers | Careers | About | About | Careers | Careers | Careers | Careers | Benefits | Careers | Careers | Careers | Careers | About | About | About | About
Symbol: BIIB
Recent Price: $150.19
Industry: Drug Manufacturers - General
CEO: Mr. Christopher A. Viehbacher
Sector: Healthcare
Employees: 7570
Address: 225 Binney Street, Cambridge, MA 02142
Phone: 617 679 2000
Leadership
- Christopher A. Viehbacher, President and Chief Executive Officer
- Susan H. Alexander, Chief Legal Officer
- Ginger Gregory, Ph.D., Chief Human Resources Officer
- Jane Grogan, Ph.D., Head of Research
- Rachid Izzar, Head of Global Product Strategy & Commercialization
- Adam Keeney, Head of Corporate Development
- Michael McDonnell, Chief Financial Officer
- Nicole Murphy, Head of Pharmaceutical Operations and Technology
- Priya Singhal, M.D., M.P.H., Head of Development and Interim Chief Medical Officer
- Alisha Alaimo, President, Head of North America
- Stephen Amato, Head of Investor Relations
- Natacha Gassenbach, Head of Corporate Affairs, Chief Communications Officer
- Fraser Hall, President, Head of Intercontinental Region
- Wolfram Schmidt, President, Head of Europe
- Kendra Thomas, Head of Global Workforce Diversity, Equity & Inclusion (DE&I)
- Caroline Dorsa, Chair of the Board
- Maria C. Freire, Ph.D., Director
- William A. Hawkins, Director
- Susan Langer, Director
- Jesus B. Mantas, Director
- Lloyd B. Minor, M.D., Director
- Monish Patolawala, Director
- Eric K. Rowinsky, M.D., Director
- Stephen A. Sherwin, M.D., Director
Last updated: 2024-12-31
Athira Pharma, Inc.
ATH-1017
Athira Pharma, Inc. is a late clinical-stage biopharmaceutical company focused on developing small molecules to restore neuronal health and slow neurodegeneration, with its lead product, ATH-1017, in clinical trials for Alzheimer's and Parkinson's diseases.
Symbol: ATHA
Recent Price: $0.55
Industry: Biotechnology
CEO: Dr. Mark J. Litton M.B.A., Ph.D.
Sector: Healthcare
Employees: 65
Address: 18706 North Creek Parkway, Bothell, WA 98011
Phone: 425 620 8501
Last updated: 2024-12-31
NRx Pharmaceuticals, Inc.
ZYESAMI, NRX-100, NRX-101
NRX Pharmaceuticals, Inc., a clinical-stage pharmaceutical company, develops novel therapeutics for the treatment of central nervous system disorders and life-threatening pulmonary diseases.
Symbol: NRXP
Recent Price: $1.53
Industry: Biotechnology
CEO: Dr. Jonathan C. Javitt M.D., M.P.H.
Sector: Healthcare
Employees: 2
Address: 1201 Orange Street, Wilmington, DE 19801
Phone: 484 254 6134
Last updated: 2024-12-31
Neurocrine Biosciences, Inc.
INGREZZA
Neurocrine Biosciences, Inc. discovers, develops, and markets pharmaceuticals for neurological, endocrine, and psychiatric disorders. The company's portfolio includes treatments for various conditions, focusing on innovative solutions for unmet medical needs.
Symbol: NBIX
Recent Price: $137.06
Industry: Drug Manufacturers - Specialty & Generic
CEO: Mr. Kyle W. Gano Ph.D.
Sector: Healthcare
Employees: 1700
Address: 12780 El Camino Real, San Diego, CA 92130
Phone: 858 617 7600
Last updated: 2024-12-31
Omeros Corporation
Narsoplimab
Omeros Corporation is a commercial-stage biopharmaceutical company that focuses on discovering, developing, and commercializing therapeutics for inflammation, immune-related cancers, and addictive disorders.
Symbol: OMER
Recent Price: $9.74
Industry: Biotechnology
CEO: Dr. Gregory A. Demopulos M.D.
Sector: Healthcare
Employees: 198
Address: The Omeros Building, Seattle, WA 98119
Phone: 206 676 5000
Last updated: 2024-12-31
Neumora Therapeutics, Inc. Common Stock
navacaprant (NMRA-140)
Neumora Therapeutics, Inc. is a clinical-stage biopharmaceutical company focused on developing therapeutic treatments for brain diseases, neuropsychiatric disorders, and neurodegenerative diseases. Key programs include navacaprant for major depressive disorder, and several promising treatments in various stages of clinical and preclinical trials targeting conditions such as Alzheimer's, schizophrenia, and Parkinson's disease.
About | About | Contact | Careers | Careers | Careers | About | About | About | About | About | Careers | About | About | About | Careers | Jobs
Symbol: NMRA
Recent Price: $11.06
Industry: Biotechnology
CEO: Mr. Henry O. Gosebruch
Sector: Healthcare
Employees: 108
Address: 490 Arsenal Way, Watertown, null 02472
Phone: 857 760 0900
Last updated: 2024-12-31
Reneo Pharmaceuticals, Inc.
REN001
Reneo Pharmaceuticals, Inc., a clinical-stage pharmaceutical company, focuses on developing therapies for patients with rare genetic mitochondrial diseases. Its primary product, REN001, is a selective peroxisome proliferator-activated receptor delta agonist currently in clinical trials.
About | About | About | Management | Directors | Contact | Contact | Careers | Careers | About | About | About
Symbol: RPHM
Recent Price: $18.20
Industry: Biotechnology
CEO: Mr. Gregory J. Flesher
Sector: Healthcare
Employees: 8
Address: 18575 Jamboree Road, Irvine, CA 92612
Phone: 619 733 3852
Last updated: 2024-12-31
Reviva Pharmaceuticals Holdings, Inc.
RP5063
Reviva Pharmaceuticals Holdings, Inc. is a clinical-stage biopharmaceutical company focused on discovering, developing, and commercializing next-generation therapeutics for unmet medical needs, particularly in central nervous system, respiratory, cardiovascular, metabolic, and inflammatory diseases.
Symbol: RVPH
Recent Price: $1.81
Industry: Biotechnology
CEO: Dr. Laxminarayan Bhat Ph.D.
Sector: Healthcare
Employees: 15
Address: 19925 Stevens Creek Boulevard, Cupertino, CA 95014
Phone: 408 501 8881
Last updated: 2024-12-31
Alto Neuroscience, Inc.
ALTO-100, ALTO-300, ALTO-101, ALTO-203, ALTO-202
Alto Neuroscience, Inc. is a clinical-stage biopharmaceutical company specializing in psychiatry drug development, with a range of innovative treatments targeting major depressive disorder and cognitive impairments.
Symbol: ANRO
Recent Price: $4.20
Industry: Biotechnology
CEO: Dr. Amit Etkin M.D., Ph.D.
Sector: Healthcare
Employees: 78
Address: 369 South San Antonio Road, Los Altos, CA 94022
Phone: (650) 200-0412
Last updated: 2024-12-31
ACADIA Pharmaceuticals Inc.
NUPLAZID
ACADIA Pharmaceuticals Inc. is a biopharmaceutical company committed to the development and commercialization of small molecule drugs to treat unmet medical needs in central nervous system disorders. Key products and developments include NUPLAZID for Parkinson's disease-related psychosis and a diverse pipeline addressing Alzheimer's disease, schizophrenia, Rett syndrome, and pain management.
Symbol: ACAD
Recent Price: $16.69
Industry: Biotechnology
CEO: Ms. Catherine E. Owen Adams
Sector: Healthcare
Employees: 597
Address: 12830 El Camino Real, San Diego, CA 92130
Phone: 858 558 2871
Last updated: 2024-12-31
Alzamend Neuro, Inc.
AL001 and AL002
Alzamend Neuro, Inc., an early clinical-stage biopharmaceutical company, focuses on developing products for neurodegenerative and psychiatric disorders. Their pipeline includes AL001 for Alzheimer's and psychiatric disorders, and AL002 for Alzheimer's disease using a novel vaccine approach.
About | About | Contact | Contact | Contact | Contact | Careers | About | About | About | About | About
Symbol: ALZN
Recent Price: $1.20
Industry: Biotechnology
CEO: Mr. Stephan Jackman
Sector: Healthcare
Employees: 4
Address: 3500 Lenox Road NE, Atlanta, GA 30326
Phone: 844 722 6333
Last updated: 2024-12-31
CervoMed Inc.
neflamapimod
Cervo Med Inc. is a clinical-stage biotechnology company focused on developing and commercializing drug treatments for neurodegenerative diseases, including neflamapimod for conditions like dementia with Lewy bodies, Alzheimer's diseases, and brain stroke recovery.
Symbol: CRVO
Recent Price: $2.39
Industry: Biotechnology
CEO: Dr. John J. Alam M.D.
Sector: Healthcare
Employees: 8
Address: 20 Park Plaza, Boston, MA 02116
Phone: 617-744-4400
Last updated: 2024-12-31
Mineralys Therapeutics, Inc.
lorundrostat
Mineralys Therapeutics, Inc. is a clinical-stage biopharmaceutical company focused on developing therapies for hypertension and associated cardiovascular diseases, with its lead product candidate being lorundrostat.
Symbol: MLYS
Recent Price: $12.52
Industry: Biotechnology
CEO: Mr. Jon Congleton
Sector: Healthcare
Employees: 28
Address: 150 N. Radnor Chester Rd., Radnor, PA 19087
Phone: 888-378-6240
Last updated: 2024-12-31
Minerva Neurosciences, Inc.
Roluperidone
Minerva Neurosciences, Inc. is a clinical-stage biopharmaceutical company focused on developing and commercializing treatments for central nervous system diseases, including schizophrenia and Parkinson's disease.
Symbol: NERV
Recent Price: $2.29
Industry: Biotechnology
CEO: Dr. Remy Luthringer Ph.D.
Sector: Healthcare
Employees: 9
Address: 1601 Trapelo Road, Waltham, MA 02451
Phone: 617 600 7373
Leadership
- Remy Luthringer, PhD, Executive Chairman of the Board, Chief Executive Officer
- Geoff Race, FCMA, MBA, President
- Michael Davidson, M.D., Chief Medical Officer
- Frederick Ahlholm, CPA, Chief Financial Officer
- Joseph Reilly, Senior Vice President and Chief Operating Officer
- Jay Saoud, PhD, Consultant
- Hans Peter Hasler, Board Member
- Jan van Heek, Board Member
- David Kupfer, MD, Board Member
- Fouzia Laghrissi-Thode, MD, Board Member, Chief Executive Officer of DalCor Pharmaceuticals
Last updated: 2024-12-31
Neurogene Inc.
NGN-401, NGN-101
Neurogene Inc. develops life-changing genetic medicines for patients and their families affected by neurological diseases, focusing on gene therapy products like NGN-401 for Rett syndrome and NGN-101 for neuronal ceroid lipofuscinosis subtype 5 batten disease.
About | Contact | Contact | Careers | Jobs | Jobs | Jobs | Benefits | Jobs | Jobs | Jobs | Jobs | Careers | About | About | About
Symbol: NGNE
Recent Price: $22.28
Industry: Biotechnology
CEO: Dr. Rachel L. McMinn Ph.D.
Sector: Healthcare
Employees: 91
Address: 535 W 24th Street, New York, NY 10011
Phone: (877) 237-5020
Last updated: 2024-12-31
NeuroBo Pharmaceuticals, Inc.
ANA001
A clinical-stage biotechnology company developing therapies for neurodegenerative, infectious, and cardiometabolic diseases.
Symbol: NRBO
Recent Price: $2.36
Industry: Biotechnology
CEO: Mr. Hyung-Heon Kim
Sector: Healthcare
Employees: 8
Address: 200 Berkeley Street, Boston, MA 02116
Phone: 857 702 9600
Last updated: 2024-12-31
Trevena, Inc.
OLINVYK (Oliceridine) injection
Trevena, Inc. is a biopharmaceutical company focused on developing and commercializing novel medicines for central nervous system disorders, with products like OLINVYK and collaborations such as with Imperial College London.
Symbol: TRVN
Recent Price: $1.50
Industry: Biotechnology
CEO: Ms. Carrie L. Bourdow
Sector: Healthcare
Employees: 23
Address: 955 Chesterbrook Boulevard, Chesterbrook, PA 19087
Phone: 610 354 8840
Leadership
- Carrie L. Bourdow, President and Chief Executive Officer
- Mark A. Demitrack, MD, Senior Vice President, Chief Medical Officer
- Barry Shin, Executive Vice President, Chief Operating Officer and Chief Financial Officer
- Robert T. Yoder, Senior Vice President, Chief Business Officer, Head of Commercial Operations & Chief Compliance Officer
- Scott Braunstein, M.D., Lead Independent Director
- Dr. Mark Corrigan, Acting CEO
- Marvin H. Johnson, Jr., Board Member
- Jake R. Nunn, Board Member
- Anne M. Phillips, M.D., Board Member
- Barbara Yanni, Board Member
Last updated: 2024-12-31
Titan Pharmaceuticals, Inc.
Pro Neura
Titan Pharmaceuticals, Inc. is a pharmaceutical company developing therapeutics for chronic diseases utilizing the Pro Neura drug delivery platform. Its products include the Probuphine implant for opioid use disorder treatment, among other programs for chronic pruritus, opioid relapse prevention, HIV prevention, and contraception.
About | About | Leadership | Directors | About | Contact | Directors | Directors | Directors | Careers | About
Symbol: TTNP
Recent Price: $3.40
Industry: Biotechnology
CEO: Jennifer Kiernan
Sector: Healthcare
Employees: 4
Address: 400 Oyster Point Boulevard, South San Francisco, CA 94080-1958
Phone: 650 244 4990
Leadership
- Dato’ Seow Gim Shen, Chief Executive Officer and Chairman of the Board of Directors
- Avraham Ben-Tzvi, Founder
- Brynner Chiam, Vice President of Finance and Tax
- Firdauz Edmin Bin Mokhtar, Chief Executive Officer
- Francisco Osvaldo Flores García, Managing Partner
Last updated: 2024-12-31
Minerva Surgical, Inc.
Minerva ES Endometrial Ablation System, Genesys HTA Endometrial Ablation System, Symphion Tissue Removal System, Resectr Tissue Resection Device
Minerva Surgical, Inc. is a commercial-stage medical technology company providing minimally invasive solutions for uterine healthcare needs of women in the United States, offering various endometrial ablation and tissue removal systems.
Symbol: UTRS
Recent Price: $0.00
Industry: Medical - Healthcare Information Services
CEO: Mr. Darrin Hammers
Sector: Healthcare
Employees: 174
Address: 4255 Burton Drive, Santa Clara, CA 95054
Phone: 855 646 7874
Last updated: 2024-12-31
Praxis Precision Medicines, Inc.
PRAX-114, PRAX-944, PRAX-562, PRAX-222, KCNT1 program
Praxis Precision Medicines, Inc. is a clinical-stage biopharmaceutical company focused on developing therapies for central nervous system disorders characterized by neuronal imbalance, with multiple products in different stages of clinical trials.
Symbol: PRAX
Recent Price: $76.26
Industry: Biotechnology
CEO: Mr. Marcio Silva De'Souza M.B.A.
Sector: Healthcare
Employees: 82
Address: 99 High Street, Boston, MA 02110
Phone: 617 300 8460
Last updated: 2024-12-31